Variable | n (%) |
---|---|
Mean age at the time of presentation, years | 65 [40-89]* |
Median duration of the symptoms, months | 3 [0-76]* |
Sex | |
Male | 82 (75) |
Female | 27 (25) |
Site of primary tumor | |
Oropharynx | 69 (63) |
Hypopharynx | 40 (37) |
T category | |
T1 | 13 (12) |
T2 | 40 (37) |
T3 | 21 (19) |
T4 | 35 (32) |
N category | |
N0 | 63 (58) |
N1 | 16 (15) |
N2 | 27 (25) |
N3 | 3 (3) |
M category | |
M0 | 105 (96) |
M1 | 4 (4) |
Stage | |
S I | 9 (8) |
S II | 25 (23) |
S III | 21 (19) |
S IV | 54 (50) |
Histologic differentiation | |
Well | 26 (24) |
Moderate | 48 (44) |
Poor | 35 (32) |
Karnofsky performance status score | |
≥ 70% | 72 (66) |
< 70% | 37 (34) |
Primary treatment | |
Radiotherapy | 69 (63) |
Surgery and radiotherapy | 31 (28) |
Surgery | 5 (5) |
No cancer specific treatment | 4 (4) |
Recurrence | |
No | 37 (34) |
Yes | 41 (38) |
No response | 31 (28) |
Second primary tumor | |
No | 99 (91) |
Yes | 10 (9) |
Median OS, months | 20.9 [1.1-401.3]* |